4//SEC Filing
Flowers Lee 4
Accession 0001209191-21-067740
CIK 0001828673other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 12:10 PM ET
Size
7.1 KB
Accession
0001209191-21-067740
Insider Transaction Report
Form 4
Flowers Lee
SVP of Business Development
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-12-01−4,285→ 12,857 totalExercise: $0.14Exp: 2029-12-18→ Common Stock (4,285 underlying) - Exercise/Conversion
Common Stock
2021-12-01$0.14/sh+4,285$600→ 95,952 total
Footnotes (1)
- [F1]20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866254
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 12:10 PM ET
- Size
- 7.1 KB